Companies / Hungary
Egis Blossoms Overseas
August 2007 | Industry NewsHungarian drugmaker Egis is showing strong growth in the export sector, with overseas sales expanding 12.8% in Q207 compared to the same period in 2006. Domestic performance has not been as strong, however, up just 5.1%, although BMI considers this to be a satisfactory result considering the impact of recent regulatory changes.
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Emerging Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Emerging Europe Pharma & Healthcare Insight please click on the trial link below.
